Suntory Global Spirits Inc. produces and sells spirits. It offers products, such as bourbon, scotch whisky, Canadian whisky, Japanese whisky, Irish whiskey, rye whisky, Spanish whisky, tequila, vodka, cognac, rum, cordials and liqueurs, and ready-to-drink under the brands including Jim Beam, Maker’s Mark, Suntory Whisky Kakubin, Knob Creek, Yamazaki, Hakushu, Hibiki, Teacher’s, Laphroaig, Bowmore, Canadian Club, Courvoisier, Hornitos, Sauza, EFFEN, Pinnacle, Sipsmith, and Midori. Suntory Global Spirits Inc. was formerly known as Beam Suntory, Inc. and changed its name to Suntory Global Spirits Inc. in April 2024. Suntory Global Spirits Inc. was founded in 1904 and is based in New York, New York, with additional offices in Chicago, Illinois; Madrid, Spain; London, United Kingdom; Singapore; Shanghai, China; Sydney, Australia; Tokyo, Japan; and Gurgaon, India. Suntory Global Spirits Inc. operates as a subsidiary of Suntory Holdings Limited.
Pioneering Base Editing | BEAM Therapeutics leads in precision genetic medicines, with promising Phase 1/2 trials for sickle cell disease and innovative approaches to gene therapy |
Financial Runway | Despite operating losses, BEAM maintains strong liquidity with a current ratio of 8.81, supporting ongoing R&D investments in its cutting-edge pipeline |
Analyst Optimism | Price targets range from $24 to $80, reflecting varied expectations for BEAM's potential in the competitive gene editing landscape |
Future Catalysts | Key milestones include BEAM-101 and BEAM-302 data releases, potential BLA filing, and updates on the groundbreaking ESCAPE program |